Winton Group’s Korro Bio KRRO Stock Holding History

Winton Group’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-418	Closed	-$148K	–	1221
2021 Q3	$148K	Buy	418 +133	+47%	+$52.3K	0.01%	1269
2021 Q2	$142K	Buy	+285	New	+$139K	0.01%	1371

Other funds holding KRRO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SDIC

South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winton Group's KRRO Position: Q4 2021 in Review

Winton Group sold out of Korro Bio (KRRO) in Q4 2021, closing a stake of 418 shares — an estimated $148K sold.

Winton Group first reported a position in KRRO in Q2 2021 and held it in 2 quarters. The position peaked at $148K in Q3 2021. 82 funds tracked by Wall St. Rank hold KRRO as of Q4 2021.

Winton Group reported no remaining Korro Bio position as of Q4 2021 after selling out during the quarter.
Winton Group sold 418 Korro Bio shares in Q4 2021, an estimated $148K.
Winton Group first reported a position in Korro Bio in Q2 2021 and held it in 2 quarters.
Winton Group's Korro Bio position peaked at $148K in Q3 2021.
82 funds tracked by Wall St. Rank held Korro Bio as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.